F Rüfer, M A Varde, J Roider. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AgedAngiogenesis Inhibitors/administration & dosageAnti-Inflammatory Agents/administration & dosageAntibodies, Monoclonal/administration & dosageAntibodies, Monoclonal, HumanizedBevacizumabDrug Therapy, CombinationExudates and Transudates/metabolismFemaleHumansInjectionsMicrophthalmos/complicationsSyndromeTomography, Optical CoherenceTriamcinolone/administration & dosageUveal Diseases/drug therapyVitreous Body
Substances: See more » Angiogenesis InhibitorsAnti-Inflammatory AgentsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedTriamcinoloneBevacizumab
Year: 2008 PMID: 18516783 DOI: 10.1055/s-2008-1027179
Source DB: PubMed Journal: Klin Monbl Augenheilkd ISSN: 0023-2165 Impact factor: 0.700